Tokyo (JCNN) - Alfresa Holdings (TSE: 2784) has announced that its subsidiary Alfresa Pharma has launched the Hemotect NS-Plus C, an automated immunochemical analyzer, and its proprietary reagent Nescoat HemoPlus for fecal occult blood tests.
Tokyo (JCNN) - Alfresa Holdings (TSE: 2784) has announced that its subsidiary Alfresa Pharma has launched the Hemotect NS-Plus C, an automated immunochemical analyzer, and its proprietary reagent Nescoat HemoPlus for fecal occult blood tests.